+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

U.S. Office Based Labs Market Size, Share & Trends Analysis Report by Modality (Single-specialty, Multi-specialty), by Service (Cardiac, Endovascular Intervention), by Specialist, and Segment Forecasts, 2020 - 2027

  • ID: 4832399
  • Report
  • February 2020
  • Region: United States
  • 120 pages
  • Grand View Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Boston Scientific
  • Cardiovascular Coalition
  • Envision Healthcare
  • GE Healthcare
  • GE Healthcare
  • MORE
the U.S. office based labs market size is expected to reach USD 16.8 billion by 2027, It is projected to register a CAGR of around 9% during the forecast period. Increasing prevalence of target diseases and rising preference for minimally invasive procedures in outpatient settings are major factors driving demand for office-based labs (OBL) in the U.S. High prevalence of risk factors such as smoking, high blood pressure, diabetes, and high cholesterol, in combination with rising geriatric population, are expected to increase the incidence of Peripheral Artery Diseases (PAD). The resultant surge in the number of procedures performed for their treatment is anticipated to fuel the OBL market.

More than 250 million people worldwide suffer from peripheral artery diseases and their prevalence increased by 24% between 2000 and 2010. The trend is expected to continue over the coming years. Low-income countries witnessed a 29% growth in the number of individuals suffering from PADs in the past decade, while high-income countries witnessed a growth of 13% during the same span. PADs increase the risk of stroke and heart attack and often lead to ischemic amputations. According to an estimation, 150,000 cases of ischemic amputations are recorded every year in the U.S. alone.

Many service providers, such as National Cardiovascular Partners and Envision Healthcare and Surgery Partners, provide services related to office-based surgery to patients in the U.S. at an affordable cost.

Further key findings from the study suggest:
  • Single specialty OBLs spearheaded the market in 2019, whereas hybrid office-based labs are anticipated to witness high growth during the forecast period. Single-specialty labs offer more patient-centric treatments while hybrid models offer more profitability with multiple facilities under one roof
  • Peripheral Vascular Intervention (PVI) service segment dominated the U.S. office-based labs market in 2019, owing to a high prevalence of atherosclerosis in the country. A large number of balloon angioplasty and stenting procedures for blocked arteries and veins has also aided segment growth
  • Vascular surgeons are leading specialist service providers in OBLs and the segment held a major market share in 2019, attributed to the rising burden of vascular diseases in the country. All the major vascular surgeries such as aortic, mesenteric, renal, subclavian, iliofemoral, tibia, and pedal are performed by vascular surgeons in office settings
  • In the U.S., almost 70% of surgical procedures are performed in outpatient settings, out of which, around 25% are performed in physicians’ office
  • Key suppliers of vascular intervention devices include Abbott, Medtronic, Boston Scientific, and Cardiovascular System, Inc., and Cardinal Health, Inc. Mergers and acquisition, technological advancements, and new product launch are some of the strategies followed by major players in the market.
  • In August 2019, Boston Scientific acquired BTG PLC to expand its portfolio of minimally-invasive surgical devices

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Boston Scientific
  • Cardiovascular Coalition
  • Envision Healthcare
  • GE Healthcare
  • GE Healthcare
  • MORE
Chapter 1 Research Objective
1.1 Objective - 1
1.2 Objective - 2
1.3 Objective - 3
1.4 Objective - 4

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Modality
2.2.2 Services
2.2.3 Specialist
2.2.4 Region
2.3 Competitive Insights
2.4 U.S. Office-Based Labs (OBL) Market Snapshot

Chapter 3 U.S. Office-Based Labs (OBLs) Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Market Segmentation
3.3 Penetration and Growth Prospect Mapping
3.3.1 Analysis
3.4 U.S. Office-Based Labs (OBLs) Market: Regulatory Framework & Reimbursement Scenario
3.4.1 U.S. Office-Based Labs (OBLs) market: regulatory framework
3.4.2 U.S. office-based labs market: Reimbursement scenario
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Increasing prevalence of target diseases
3.5.1.2 Growing preference to minimally invasive procedures
3.5.2 Market restraint analysis
3.5.2.1 High risk options for severe cases
3.5.2.2 Lack of technical training for the MIS procedure
3.5.3 Industry Opportunity
3.5.3.1 Approval of endovascular procedures in office-based labs
3.5.3.2 Flexibility for physicians to convert to OBLs
3.6 Business Environment Analysis Tools
3.6.1 Industry analysis - Porter’s
3.6.1.1 Competitive rivalry: High
3.6.1.2 Threat of new entrants
3.6.1.3 Bargaining power of buyers
3.6.1.4 Bargaining power of suppliers
3.6.1.5 Threat of substitutes
3.6.2 PEST analysis
3.6.2.1 Political landscape
3.6.2.2 Economic and social landscape
3.6.2.3 Technology landscape
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Joint ventures & partnerships
3.7.2 Mergers & acquisitions

Chapter 4 U.S. Office-Based Labs (OBLs) Market: Modality Estimates & Trend Analysis
4.1 Segment Dashboard
4.2 U.S. Office-Based Labs (OBLs) Market: Modality Movement Analysis, USD Million, 2019 & 2027
4.2.1 Single specialty labs
4.2.1.1 Single specialty labs market, 2016 - 2027 (USD Million)
4.2.1 Multi specialty labs
4.2.2 Hybrid labs

Chapter 5 U.S. Office-Based Labs (OBLs) Market: Services Estimates & Trend Analysis
5.1 Segment Dashboard
5.2 U.S. Office-Based Labs (OBLs) Market: Services Movement Analysis, USD Million, 2019 & 2027
5.2.1 Peripheral vascular intervention
5.2.1.1 Peripheral vascular intervention market, 2016 - 2027 (USD Million)
5.2.2 Endovascular intervention
5.2.3 Cardiac
5.2.4 Interventional radiology
5.2.5 Venous
5.2.6 Others

Chapter 6 U.S. Office-Based Labs (OBLs) Market: Specialist Estimates & Trend Analysis
6.1 Segment Dashboard
6.2 U.S. Office-Based Labs (OBLs) Market: Specialist Movement Analysis, USD Million, 2019 & 2027
6.2.1 Vascular surgeon
6.2.1.1 Vascular surgeon market, 2016 - 2027 (USD Million)
6.2.2 Interventional cardiologist
6.2.3 Interventional radiologist
6.2.4 Others

Chapter 7 U.S. Office-Based Labs (OBLs) Market: Regional Estimates & Trend Analysis
7.1 U.S.
7.1.1 U.S. Office-Based Labs (OBLs) market estimates and forecasts, 2016 - 2027 (USD Million)
7.2 U.S Office-Based Labs (OBLs) Market: Top 5 States
7.2.1 Penetration analysis: top 5 states
7.2.1.1 Analysis
7.3 Pricing Analysis
7.3.1 Average cost of major procedures performed in office-based labs
7.3.2 Average cost of major devices used in office-based labs
7.3.3 Average cost of setting up an office-based lab

Chapter 8 Competitive & Vendor Landscape
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.1.1 Analysis
8.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
8.2.1 Analysis
8.3 Vendor Landscape
8.3.1 Partnerships
8.3.2 Marketing & promotions
8.4 Company market position analysis (Revenue, product portfolio, geographic presence, employee strength, strategic initiatives)
8.4.1 BY suppliers
8.4.1.1 Market position analysis: Imaging devices manufacturer
8.4.1.1.1 Analysis
8.4.1.2 Market position analysis: Vascular intervention devices manufacturer
8.4.1.2.1 Analysis
8.4.2 by service provider
8.4.2.1 Analysis
8.5 Company Profiles
8.5.1 Suppliers
8.5.1.1 GE Healthcare
8.5.1.1.1 Company overview
8.5.1.1.2 Financial performance
8.5.1.1.3 Product benchmarking
8.5.1.1.4 Strategic initiatives
8.5.1.1.5 SWOT analysis
8.5.1.2 Philips Healthcare
8.5.1.3 GE Healthcare
8.5.1.4 Siemens Healthcare
8.5.1.5 Medtronic PLC
8.5.1.6 Boston Scientific
8.5.1.7 Abbott
8.5.1.8 Cardiovascular System, Inc.
8.5.2 Service providers
8.5.2.1 Envision Healthcare
8.5.1.1.1 Company overview
8.5.1.1.2 Financial performance
8.5.1.1.3 Service benchmarking
8.5.1.1.4 Strategic initiatives
8.5.1.1.5 SWOT analysis
8.5.2.2 Surgery Care Affiliates (SCA)
8.5.2.3 Tenet Healthcare Corporation
8.5.2.4 National Cardiovascular Partners, LP
8.5.2.5 Surgery Partners
8.5.2.6 Cardiovascular Coalition

Chapter 9 Recommendations
9.1 KOL Commentary
9.2 Recommendations

Chapter 10 Research Methodology & Scope
10.1 Research Methodology
10.1.1 Information procurement
10.1.1.1 Purchased database:
10.1.1.2 internal database
10.1.2 Primary research
10.2 Research Scope and Assumptions
10.3 List to Data Sources

Chapter 11 Report FAQs
11.1 How do I trust your report quality/data accuracy?
11.2 My research requirement is very specific; can I customize this report?
11.3 I have a pre-defined budget. Can I buy chapters/sections of this report?
11.4 How do you arrive at these market numbers?
11.5 Who are your clients?
11.6 How will I receive this report?

Chapter 12 Appendix

Chapter 13 Compass - Cloud Based Report Delivery Platform

Chapter 14 Related Reports


Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 4
  • GE Healthcare
  • Philips Healthcare
  • GE Healthcare
  • Siemens Healthcare
  • Medtronic PLC
  • Boston Scientific
  • Abbott
  • Cardiovascular System, Inc.
  • Envision Healthcare
  • Surgery Care Affiliates (SCA)
  • Tenet Healthcare Corporation
  • National Cardiovascular Partners, LP
  • Surgery Partners
  • Cardiovascular Coalition
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll